Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-05-29 @ 2:41 AM
Study NCT ID:
NCT05768503
Status:
RECRUITING
Last Update Posted:
2023-03-14
First Post:
2023-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Microsatellite-stable Colorectal Cancer | View |